Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $475.82
EBIT (Mil) (FY) $156.32
EBIT (Mil) (MRQ) $-32.79
EBIT (Mil) (TTM) $-207.89
EBITDA (Mil) (FY) $159.22
EBITDA (Mil) (MRQ) $-31.89
EBITDA (Mil) (TTM) $-204.37
Net Income Excluding Extraordinary Items (Mil) (FY) $132.24
Net Income Including Extraordinary Items (Mil) (FY) $132.24
Diluted EPS Excluding Extraordinary Items (FY) $1.62
Diluted EPS Including Extraordinary Items (FY) $1.62

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --%

Ratios

Price to Revenue (TTM) $3.84
Price to Revenue (MRQ) $4.22
Price to Revenue (FY) $2.94
Price To Cash Flow (TTM) --
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) $10.34
Price to Book (MRQ) $10.66
Price to Book (FY) $4.70
Total Debt to Equity (MRQ) (%) 311.39%
Total Debt to Equity (FY) (%) 144.30%
Current Ratio (MRQ) $2.10
Current Ratio (FY) $5.27

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 73.76%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv